Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Spring;21(1):11-37.
doi: 10.1155/2010/580340.

Canadian practice guidelines for surgical intra-abdominal infections

Affiliations

Canadian practice guidelines for surgical intra-abdominal infections

Anthony W Chow et al. Can J Infect Dis Med Microbiol. 2010 Spring.
No abstract available

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
Ratio of clinical success rates over comparators in randomized controlled trials among 63 monotherapy regimens for complicated intra-abdominal infections. Data are expressed as mean ± 95% CIs of study regimens over the comparator in each trial. Number of studies for the antimicrobial groups are shown in parentheses. Second-generation (gen)cephalosporins include cefoxitin, cefotetan, cefuroxime and cefamandole. Third-gen cephalosporins include cefoperazone with/without sulbactam. Antianaerobic fluoroquinolones include moxifloxacin, clinafloxacin and trovafloxacin. Data were compiled from published results of prospective randomized comparative trials (,,,,,,,–,,–,,–243)
Figure 2)
Figure 2)
Ratio of clinical success rates over comparators in randomized controlled trials among 39 combination regimens for complicated intra-abdominal infections. Data are expressed as mean ± 95% CIs of study regimens over the comparator in each trial. Number of studies for the antimicrobial groups are shown in parentheses. Second-generation (gen) cephalosporins include cefuroxime. Third- or fourth-gen cephalosporins include cefotaxime, ceftriaxone and cefepime. Data were compiled from published results of prospective, randomized comparative trials (,,,,,,,,–,,,,–,–,–247)

References

    1. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997–1005. - PubMed
    1. Krukowski ZH, Matheson NA. Ten-year computerized audit of infection after abdominal surgery. Br J Surg. 1988;75:857–61. - PubMed
    1. Weiss G, Meyer F, Lippert H. Infectiological diagnostic problems in tertiary peritonitis. Langenbecks Arch Surg. 2006;391:473–82. - PubMed
    1. Cheadle WG, Spain DA. The continuing challenge of intra-abdominal infection. Am J Surg. 2003;186:15S–22S. - PubMed
    1. Christou NV, Barie PS, Dellinger EP, et al. Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg. 1993;128:193–8. - PubMed

LinkOut - more resources